AbbVie Inc. is a publicly traded company with a symbol of ‘ABBV’ and its shares are listed at the New York Stock Exchange (NYSE). The current market capitalization of the company is 26.7 bln US dollars and the share price stands at 151.06 US dollars. The market capitalization has been fluctuating around 25-26 bln US dollars since 2nd February 2023, although there was a steep increase on 1st February to 25.9 bln US dollars. The year high for AbbVie Inc. came on 11th May 2020 when it reached 175.91 US dollars and the year low has been 134.09 which was recorded on 3rd August 2020.
The 50-day average share price of AbbVie Inc is 156.29 US dollars while the 200-day average stands at 148.96 US dollars, indicating that the stock has been in an upward trend over the past one year with only minor fluctuations in between them. Furthermore, according to recent earnings announcement on 27th April 2023, the EPS of AbbVie Inc is 6.63 and PE ratio stands at 22.78 which implies that investors consider this stock as undervalued security which can generate good returns in future when compared to other competitors in same industry or sector.
To conclude, despite short term fluctuations based on several factors such as economic cycles or investor sentiment towards pharmaceuticals industry, AbbVie Inc’s stock trend from past one year indicates bullish outlook and current market cap of 26 bln US dollars suggests strong financial position of this company going forward into future quarters or years provided that no major changes occur in fundamentals or external environment during this period which can affect company’s profitability adversely in long run negatively impacting investors’ return on their investments .
